Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, April 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Cell Culture Media Bags Market Size, Trends and Insights By Capacity (Large-sized Bags, Medium-sized Bags, Small-sized Bags), By...
Levoit Lands on Harvey Norman, Making Cleaner Air More Accessible for Australians
GlobeNewswire, Inc.
SYDNEY, April 28, 2026 (GLOBE NEWSWIRE) -- Levoit, a global air purification brand under VeSync, is now available on Harvey Norman Online Store, expanding access to air purifiers for Australian households as working from home continues to reshape...
Aexa Aerospace® and SpacePort Australia® Work together to create the world’s first deductive medical AI
EIN Presswire
Aexa Aerospace® and SpacePort Australia® Work together to create the world’s first deductive medical AI to support space exploration.
Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload
GlobeNewswire, Inc.
Patent covers proprietary 2nd generation Thailanstatin analog payload designed for use in ADCs (antibody-drug conjugates) targeting cancer Approval strengthens Akari’s global intellectual property across all major markets and supports advancement...
Digital Therapeutics Set to Surge to Historic Heights by 2036 Across Multiple Segments – Towards Healthcare Research and Consulting
GlobeNewswire, Inc.
Ottawa, April 28, 2026 (GLOBE NEWSWIRE) -- The global digital therapeutics market size is calculated at USD 12.58 billion in 2026 and is expected to reach around USD 114.37 billion by 2035, growing at a CAGR of 27.8% for the forecasted period.
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
GlobeNewswire, Inc.
MINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced today that it has received full regulatory clearance from the French National...
Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand
GlobeNewswire, Inc.
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Nucleus Genomics today announced an IVF+ partnership with the Fertility Institute of Hawaii, bringing its advanced carrier screening and embryo analysis to Hawaii's largest IVF practice.
Rezibase Launches Australia's Leading Respiratory and Sleep Lab Platform in the UK at ARTP 2026
EIN Presswire
UNITED KINGDOM, April 27, 2026 /EINPresswire.com/ -- Rezibase, a specialized AI-powered cloud-based reporting system for clinical physiology labs, announced its official launch into the United Kingdom and Ireland markets.
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
GlobeNewswire, Inc.
Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response and could potentially support a traditional approval On track for expected CRL response submission by end of 2026 WATERTOWN, Mass., June 09,...
Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma
GlobeNewswire, Inc.
- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham - Elraglusib will be assessed in combination with dinutuximab...
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy
GlobeNewswire, Inc.
– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population, dosing regimen, and treatment duration – – FDA agrees on UMSARS Part I as primary endpoint after ATH434 demonstrated...
SafeLane Healthcare Drives Better NDIS Outcomes Through Person-Centred Support Coordination in Melbourne
EIN Presswire
SafeLane Healthcare improves NDIS outcomes in Melbourne through person-centred support coordination, empowering independence and tailored care.
Australia's Share Market Opens Monday in Red
MENAFN
(MENAFN) Australia's share market opened sharply lower Monday, dragged down by surging global oil prices as the Middle East conflict continued to rattle investor confidence worldwide.
Rapid Nutrition Establishes Flagship Platform to Strengthen Multi-Channel Strategy in Australia
GlobeNewswire, Inc.
LONDON, April 20, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC (Euronext Growth: ALRPD), a global HealthTech company focused on evidence-based nutrition brands, announces that it has entered into a binding agreement to acquire established health...
Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness
GlobeNewswire, Inc.
MELBOURNE, Australia and NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today supports the White House Executive Order...
Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Automated Insulin Delivery System Market Size, Trends and Insights By Product (Predictive Low Glucose Suspend (PLGS) System,...
Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility
GlobeNewswire, Inc.
NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative combination therapies and...
FTI Consulting Expands Data Analytics & AI Healthcare Expertise With Three Senior Hires
GlobeNewswire, Inc.
SYDNEY, April 22, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the expansion of its Health and Human Services practice with the appointment of three senior professionals in Australia.
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
GlobeNewswire, Inc.
Expansion Adds to Growing Global Trial Footprint Patient Screening and Enrollment Expected to Begin in Q2 2026 SOUTH SAN FRANCISCO, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage...
Australia Data Center Market Size, Share, Report 2026–2034
EIN Presswire
Australia data center market was USD 4.8B in 2025 and is projected to reach USD 8.2B by 2034, growing at a 5.47% CAGR (2026–2034). AUSTRALIA, March 23, 2026 /EINPresswire.com/ -- 𝗠𝗮𝗿𝗸𝗲𝘁 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄 The Australia data center market size was valued...
Sign up for:
Australian Healthcare Herald
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.